PURPOSE: A composition for preventing or treating neurodegenerative diseases is provided to effectively prevent or treat neurodegenerative diseases, especially Alzheimer's disease, and to be used as a pharmaceutical product or a health supplementary food. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains one or more selected from the group consisting of epinephrine hydrochloride, epinephrine bitartrate, norepinephrine bitartrate, levonordef...

PURPOSE: A composition containing butoconazole is provided to prevent or treat neurodegenerative diseases, especially Alzheimer's disease. CONSTITUTION: A composition for preventing or treating neurodegenerative diseases contains butoconazole, a derivative thereof, or a pharmaceutically acceptable salt thereof. The neurodegerative diseases are selected from stroke, memory loss, memory injury, dementia, Parkinson's disease, Pick disease, Creutzfeld-Kacob disease, Huntingtun's disease, and amyotro...

PURPOSE: A method for preparing (+) fluvastatin is provided to cheaply produce a large amount of the compound without expensive reagent and to prepare other statin compounds. CONSTITUTION: A method for preparing (+) flavastatin comprises: a step of reacting an indole compound of chemical formula 6 with fluorohalogenbenzene, haloisopropyl, and haloacyl aldehyde in the presence of a copper catalyst in order o prepare a compound of chemical formula 5

PURPOSE: A composition containing carbon monoxide or carbon monoxide donor for preventing or treating obesity is provided. CONSTITUTION: A composition for preventing or treating obesity contains carbon monoxide or carbon monoxide donor as an active ingredient. The carbon monoxide is generated by heme oxygenase-1. The carbon monoxide donor is RuCO(Ruthenium Carbon Monoxide), CORM-1(Mn_2CO_10 :manganese decacarbonyl), CORM-3(Ru(CO)(3)Cl(glycinate)) or CORM-A1(sodium boranocarbonate). The compositi...

PURPOSE: A tau protein hyperphosphorylation inhibitor containing pentoxifylline is provided to prevent tau hyperphosphorylation and neuron dendrite damage and to prevent or treat neuropathic diseases. CONSTITUTION: A tau protein hyperphosphorylation inhibitor contains pentoxifylline of chemical formula 1 as an active ingredient. Pentoxifyllne is used for treating or preventing disease selected from the group consisting of dementia of Alzheimers type, dementia in Parkinson's diseases, and frontot...

PURPOSE: A method for removing CD137 positive cells in vitro is provided to effectively prevent or treat diseases caused by CD137-expressing cell activity. CONSTITUTION: A method for removing CD137 positive cells in vitro comprises a step of contacting the CD137 positive cells with an anti-CD137-antibody and toxin complex. The antibody is an agonist antibody or antagonist antibody with respect to a CD137 molecule. The toxin is selected from the group consisting of: a chemotherapeutic agent selec...

PURPOSE: A pharmaceutical composition containing alpha-lipoic acid or derivative compound thereof is provided to promote the expression of thyroglobulin(Tg) or thyroid transcription factor(TTF-1). CONSTITUTION: A pharmaceutical composition for treating thyroid cancer contains alpha-lipoic acid or derivative compound thereof as an active ingredient. The derivative is dihydrolipoic acid. The compound is an inducer of differentiation which promotes the expression of a thyroid-specific gene. A healt...